Baskin v. United States

CourtDistrict Court, N.D. Ohio
DecidedAugust 20, 2024
Docket1:22-cv-00124
StatusUnknown

This text of Baskin v. United States (Baskin v. United States) is published on Counsel Stack Legal Research, covering District Court, N.D. Ohio primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Baskin v. United States, (N.D. Ohio 2024).

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF OHIO

CAZEMBIE S. BASKIN, Case No. 1:22-CV-124

Plaintiff,

-vs- JUDGE PAMELA A. BARKER

UNITED STATES OF AMERICA,

Defendant. MEMORANDUM OPINION & ORDER

This matter is before the Court upon the United States of America’s Motion for Summary Judgment filed on June 3, 2024 (“Defendant’s Motion”). (Doc. No. 42.) On June 27, 2024 Plaintiff Cazembie S. Baskin (“Plaintiff” or “Baskin”) filed Plaintiff’s Reply Brief as to Defendant’s Motion (“Plaintiff’s Opposition”). (Doc. No. 43.) On July 11, 2024, the United States filed a Reply in Support of Defendant’s Motion (“Defendant’s Reply”). (Doc. No. 44.) Upon careful review of the record and the parties’ briefs, and for the reasons set forth below, the Court grants Defendant’s Motion. Background The only claim that remains pending and that is the subject of Defendant’s Motion is a medical malpractice or medical negligence claim under the Federal Tort Claims Act, specifically that the medical care for Plaintiff’s polycystic liver disease and enlarged liver that he received while incarcerated at FCI Elkton fell below the standard of care.1 On April 19, 2023 the Court appointed

1 The “Procedural Background” set forth in Defendant’s Motion, at pages 4 and 5 of its Brief in Support, is accurate and adopted as though fully rewritten herein and therefore, will not be repeated herein. (Doc. No. 42-1, PageID #s 308-09.) pro bono counsel for Plaintiff, and it was after and because of the deposition testimony of Dr. David Kwon (“Dr. Kwon”) given on January 29, 2024, that on February 16, 2024 a Joint Motion for Conference and to Stay Deadlines was filed and granted the same day; and that pro bono counsel sought leave to withdraw and was permitted to withdraw as counsel for Plaintiff. (Doc. Nos. 36, 37.) Despite having had counsel represent him for over nine months during which time frame the Court granted three extensions of the discovery deadlines—to include the production of expert report(s)—

Plaintiff has failed to produce an expert report or any expert testimony to establish the standard of care for diagnosing and treating polycystic liver disease and enlarged liver, that FCI Elkton medical personnel breached the applicable standard of care, or that any alleged breach of the standard of care was the proximate cause of any injuries or damages claimed. The undisputed evidence adduced while Plaintiff was represented by counsel demonstrates the following concerning Plaintiff’s medical treatment while incarcerated at FCI Elkton. On August 7, 2019, Plaintiff saw Dr. Kathy McNutt at FCI Elkton complaining of episodic chest pain. (Doc. No. 42-2, PageID # 342.) At that time, Dr. McNutt was aware of the results of a chest CT scan for elevated hemi-diaphragm and an abdomen CT scan for numerous cysts and hemangioma Plaintiff had undergone in 2015. (Id., PageID # 343.) Dr. McNutt testified that when she saw Plaintiff in

August of 2019, Plaintiff having a cystic liver and hemangioma was not alarming; she was more concerned that Plaintiff might have a blood clot. (Id., PageID # 344-45.) So, Dr. McNutt ordered an echocardiogram and, as reflected in an administrative note dated September 20, 2019, the echocardiogram showed a large mass on Plaintiff’s right side and after also considering the 2015 CT scan that showed cysts, her plan was to have Plaintiff undergo advanced imaging. (Id., PageID #s 346-47.) On October 16, 2019, Dr. McNutt discussed with Plaintiff the results of a pelvis and

2 abdomen CT scan that he had undergone on October 11, 2019 that showed a massive enlargement of Plaintiff’s liver, and that his liver function tests were normal and there was no showing of liver failure. (Id., PageID #s 348-49, 356-57.) Dr. McNutt was also aware of the results of the echocardiogram that showed a large mass up against Plaintiff’s atrium. (Id.) After discussing the CT results with Dr. Woods at Trumbull Hospital who suggested to her that Plaintiff see a specialist at the Cleveland Clinic, Dr. McNutt referred Plaintiff to a specialist at the Cleveland Clinic. (Id., PageID #s 353-54.)

On October 29, 2019, Plaintiff saw gastroenterology Physician Assistant Sara Krajewski (“P.A. Krajewski”) at the Cleveland Clinic who reviewed the imaging and noted Plaintiff’s symptoms of intermittent discomfort, pain, and shortness of breath. There were no signs of cirrhosis. (Id., PageID #s 355-56.) P.A. Krajewski recommended blood work and an MRI. (Id., PageID # 357-58.) The MRI was performed on December 5, 2019 and during Plaintiff’s December 6, 2019 visit, P.A. Krajewski advised Plaintiff that the MRI showed enlarged polycystic liver with few bilateral renal cysts and cystic liver compatible with polycystic liver disease. She recommended a consultation with a liver surgeon for resection of larger cysts. (Id., PageID #s 358-61.) Given scheduling issues associated with dealing with COVID, Plaintiff was finally able to see Dr. Kwon with the Cleveland Clinic for an assessment on June 11, 2020. (Id., PageID # 366.) Dr.

Kwon is an expert in liver surgery and living donor liver transplants and was the Director of Laparoscopic Liver Surgery and now Director of Minimally Invasive Surgery at the Cleveland Clinic. (Doc. No. 42-5, PageID #s 428-29.) Dr. Kwon noted that Plaintiff had polycystic liver disease; his cysts were medium-sized and equally distributed bilaterally without any overly enlarged cyst, so cyst unroofing was not indicated; the other treatment option was a liver transplant, but it should be considered when the symptoms are debilitating as to hinder normal life, which did not correspond to

3 Plaintiff; and no further surveillance was needed until otherwise indicated. (Doc. No. 42-4.) Dr. Kwon testified that polycystic liver disease is a genetic disorder that can cause an enlarged liver and it “does not occur because of mismanagement; it does not occur because treatment was not done. It’s just you are born with it.” (Doc. No. 42-5, PageID #466.) When asked whether Plaintiff’s allegation that he has polycystic liver disease because the Bureau of Prisons had failed to treat his enlarged liver is supported by medical research, Dr. Kwon responded “no.” (Id., PageID # 465.) After evaluating

Plaintiff, Dr. Kwon determined that Plaintiff was not a candidate for surgery, there were no prescription medications that could have been prescribed to manage Plaintiff’s condition, no additional imaging or monitoring was required, and the only course of treatment for FCI Elkton to follow would be to rely on Plaintiff to report new or worsening symptoms. (Id., PageID #s 482-85.) Again, the record reflects that Plaintiff did not produce any report(s) setting forth an expert opinion detailing the standard of care for treating Plaintiff’s conditions, FCI Elkton medical personnel’s breach thereof, or that any such breach proximately caused Plaintiff’s alleged injuries. Standard of Review Summary judgment is proper “if the movant shows that there is no genuine dispute as to any material fact and the movant is entitled to judgment as a matter of law.” Fed. R. Civ. P. 56(a). “A

dispute is ‘genuine’ only if based on evidence upon which a reasonable jury could return a verdict in favor of the non-moving party.” Henderson v. Walled Lake Consol. Sch., 469 F.3d 479, 487 (6th Cir. 2006) (citing Hedrick v. W. Reserve Care Sys., 355 F.3d 444, 451 (6th Cir. 2004)).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Richards v. United States
369 U.S. 1 (Supreme Court, 1962)
Anderson v. Liberty Lobby, Inc.
477 U.S. 242 (Supreme Court, 1986)
James Lyons v. RN/HSA Suzanne Brandly
430 F. App'x 377 (Sixth Circuit, 2011)
Mooney v. Cleveland Clinic Foundation
65 F. Supp. 2d 682 (N.D. Ohio, 1999)
Ask Chemicals, LP v. Computer Packages, Inc.
593 F. App'x 506 (Sixth Circuit, 2014)
Sonjia Lindsey v. Whirlpool Corporation
295 F. App'x 758 (Sixth Circuit, 2008)
Pittman v. Experian Info. Solutions, Inc.
901 F.3d 619 (Sixth Circuit, 2018)
Fisher v. Alliance Machine Co.
947 N.E.2d 1308 (Ohio Court of Appeals, 2011)
Stevenson v. Prettyman
951 N.E.2d 794 (Ohio Court of Appeals, 2011)
Bruni v. Tatsumi
346 N.E.2d 673 (Ohio Supreme Court, 1976)
Shumaker v. Oliver B. Cannon & Sons, Inc.
504 N.E.2d 44 (Ohio Supreme Court, 1986)
MISC Berhad v. Advanced Polymer Coatings, Inc.
101 F. Supp. 3d 731 (N.D. Ohio, 2015)

Cite This Page — Counsel Stack

Bluebook (online)
Baskin v. United States, Counsel Stack Legal Research, https://law.counselstack.com/opinion/baskin-v-united-states-ohnd-2024.